Established in 1965, from a small roll of medicine for resistance war, gradually becoming a pharmaceutical enterprise with small scale and capacity, Danapha currently owns a closed system with modern production lines: Pharmaceutical factory with GMP-WHO; Pharmaceutical manufacturer and High-tech R&D Center worth nearly VND 1,500 billion in Da Nang Hi-Tech Park ... Especially, Danapha's manufacturer has been granted the Russian GMP and Ukraine GMP certification; including the PIC/S standard (Pharmaceutical Inspection Co-operation Scheme). These certifications set the premise for Danapha to continue to conquer higher standards in the future.
Including:
1. GMP-WHO NON-BETALACTAM MEDICINE FACTORY
- Total: 22,500m2
- Total invested capital: 6.0 million USD
- Standards: GMP compliant to WHO requirements for medicine factory (including GLP&GSP)GMP in Russia, GMP in Belarus
- Products: more than 200 types of products, including: Tablets, capsules, powders, injectables, syrups, topical solutions, liniments/ointments
- Capacity: Non-betalactam: 1 billion capsules/ year, injectable: 17-20 million ampoules/ year, nasal/ eye drops: 150,000 - 200,000 litres/ year, balms: 18 - 20 million units/ year
2. GMP-WHO HERBAL MEDICINE FACTORY
- Total: 10,780m2
- Total invested capital: 3.3 million USD
- Standards: GMP compliant to WHO requirements for herbal medicine factory (including GLP&GSP), GMP in Ukraine, GMP in Kazakhstan
- Products: More than 30 types of products, including: uncoated/ suger-coated/ film-coated tablets, capsules, powders, dry and viscous extracts
- Capacity: Tablets and capsules: 300 billion pills/ year
3. HI-TECH PHARMACEUTICAL FACTORY
- Total area: 7.7 ha
- Total invested capital: 35 million USD
- Standards: EU- GMP
- Products: Tablets, capsules, powders, injectables, syrups, topical solutions, liniments/ointments
- Capacity: 1.5 billion pills/ year